Due to the COVID-19 pandemic, new patient appointments are now conducted through a secure telehealth portal.

Scientific Studies and Reports

Ketamine and Esketamine in the News

Scientific American

Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain

The Food and Drug Administration’s approval in March of a depression treatment based on ketamine generated headlines, in part, because the drug represents a completely new approach for dealing with a condition the World Health Organization has labeled the leading cause of disability worldwide.

Springview Ketamine

Call Today: 630-687-1653

© 2019 Springview Ketamine Behavioral Services. 

All Rights Reserved.